Polymorphism in cytochrome P450 2E1 and interaction with other genetic risk factors and susceptibility to alcoholic liver cirrhosis.
- Authors
- Khan, Anwar Jamal; Ruwali, Munindra; Choudhuri, Gourdas; Mathur, Neeraj; Husain, Qayyum; Parmar, Devendra
- Year
- 2009
- Journal
- Mutation research
- PMID
- 19428381
- DOI
- 10.1016/j.mrfmmm.2009.02.009
The association of polymorphism in cytochrome P450 2E1 (CYP2E1), the major microsomal ethanol metabolizing enzyme and its interaction with genes, involved in detoxification of reactive oxygen species, such as glutathione-S-transferases M1 (GSTM1) and alcohol intake, gamma-aminobutyric acid receptor gamma2 (GABRG2) was studied with the risk to alcoholic cirrhosis in a case-control study. A total of 160 alcoholic cirrhotic and 125 non-alcoholic cirrhotic cases, visiting the OPD facility of Gastroenterology Department of Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGI), Lucknow, India and 250 non-alcoholic and 100 alcoholic controls having no evidence of liver disease were included in the study. PCR-based RFLP methodology was followed for genotyping studies. Our data revealed that the variant genotypes of CYP2E1 5B exhibited significant association with the alcoholic liver cirrhosis when compared to non-alcoholic controls (OR: 4.3; 95%CI: 1.5-12.4; p: 0.003) or non-alcoholic cirrhosis patients (OR: 5.4; 95%CI: 1.2-24.5; p: 0.01) or alcoholic controls (OR: 4.3; 95%CI: 0.95-19.62; p: 0.04). Haplotype approach revealed that haplotype T-A-T was found to be associated with more than 5-fold increase in risk for alcoholic cirrhosis. Likewise, combination of variant genotype of CYP2E1 5B with null genotype of GSTM1, a phase II detoxification enzyme, resulted in several fold increase in risk in alcoholic cirrhotic patients when compared with non-alcoholic controls or non-alcoholic cirrhotic patients. Further, the combination of variant genotype of CYP2E1 5B with GABRG2, significantly increased the risk upto 6.5-fold in alcoholic cirrhotic patients when compared with non-alcoholic controls thereby suggesting the role of gene-gene interaction in alcoholic cirrhosis.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genes encoding enzymes involved in ethanol metabolism. | 2012 | 23134050 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| A Genome-Wide Analysis of a Sudden Cardiac Death Cohort: Identifying Novel Target Variants in the Era of Molecular Autopsy. | Beccacece L et al. | β | 2023 | β |
| Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). | Choudhary NS et al. | β | 2021 | β |
| Genetic Variants of Alcohol Metabolizing Enzymes and Alcohol-Related Liver Cirrhosis Risk. | Ayuso P et al. | β | 2021 | β |
| Network Pharmacology Databases for Traditional Chinese Medicine: Review and Assessment. | Zhang R et al. | β | 2019 | β |
| The influence of polymorphic GSTM1 gene on the increased susceptibility of non-viral hepatic cirrhosis: evidence from observational studies. | Gu Y et al. | β | 2018 | β |
| Unraveling CYP2E1 haplotypes in alcoholics from Central Brazil: A comparative study with 1000 genomes population. | Ramos JSA et al. | β | 2018 | β |
| Development of gene polymorphisms in meditators of nonalcoholic fatty liver disease. | Wang C et al. | β | 2017 | β |
| DNA damage in peripheral blood lymphocytes and association with polymorphisms in the promoter region of the CYP2E1 gene in alcoholics from Central Brazil. | Ramos JS et al. | β | 2016 | β |
| Genetic Association and Gene-Gene Interaction Reveal Genetic Variations in ADH1B, GSTM1 and MnSOD Independently Confer Risk to Alcoholic Liver Diseases in India. | Roy N et al. | β | 2016 | β |
| Ethnic differences in presentation and severity of alcoholic liver disease. | Levy R et al. | β | 2015 | β |
| Polymorphism of Alcohol Metabolizing Gene ADH3 Predisposes to Development of Alcoholic Pancreatitis in North Indian Population. | Singh D et al. | β | 2015 | β |
| A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease. | Miele L et al. | β | 2014 | β |
| Analysis of mitochondrial transcription factor A SNPs in alcoholic cirrhosis. | Tang C et al. | β | 2014 | β |
| Association of gamma-aminobutyric acid A receptor Ξ±2 gene (GABRA2) with alcohol use disorder. | Li D et al. | β | 2014 | β |
| Polymorphisms in CYP2E1, GSTM1 and GSTT1 and anti-tuberculosis drug-induced hepatotoxicity. | Brito TC et al. | β | 2014 | β |
| Cytochrome P450 2E1: its clinical aspects and a brief perspective on the current research scenario. | Dey A | β | 2013 | β |
| Multi-ethnic cytochrome-P450 copy number profiling: novel pharmacogenetic alleles and mechanism of copy number variation formation. | Martis S et al. | β | 2013 | β |
| Roles of cytochrome P4502E1 gene polymorphisms and the risks of alcoholic liver disease: a meta-analysis. | Zeng T et al. | β | 2013 | β |
| Genes encoding enzymes involved in ethanol metabolism. | Hurley TD et al. | β | 2012 | β |
| Genetic variants of TNFΞ±, IL10, IL1Ξ², CTLA4 and TGFΞ²1 modulate the indices of alcohol-induced liver injury in East Indian population. | Roy N et al. | β | 2012 | β |
| Oxidative stress and redox signaling mechanisms of alcoholic liver disease: updated experimental and clinical evidence. | Zhu H et al. | β | 2012 | β |
| Meta-analysis: glutathione-S-transferase allelic variants are associated with alcoholic liver disease. | Marcos M et al. | β | 2011 | β |
| Omics in mechanistic and predictive toxicology. | Singh S et al. | β | 2010 | β |
| Polymorphism in glutathione-S-transferases: a risk factor in alcoholic liver cirrhosis. | Khan AJ et al. | β | 2009 | β |